Cozad Asset Management Inc Cellectar Biosciences, Inc. Transaction History

Cozad Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.5 - $6.9 $196,000 - $386,400	-56,000 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$6.1 - $10.2 $30,500 - $51,000	5,000 Added 9.8%	56,000 $37,000
Q3 2021 Nov 05, 2021	BUY	$8.2 - $12.4 $164,000 - $248,000	20,000 Added 64.52%	51,000 $47,000
Q2 2021 Jul 29, 2021	BUY	$11.8 - $18.2 $236,000 - $364,000	20,000 Added 181.82%	31,000 $37,000
Q4 2020 Feb 16, 2021	BUY	$11.2 - $27.7 $123,199 - $304,700	11,000 New	11,000 $23,000

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $13M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cozad Asset Management Inc with notifications on news.